參考文獻/References:
[1] ZHAO D W,YU M,HU K,et al.Prevalence of nontraumatic osteonecrosis of the femoral head and its associated risk factors in the Chinese population:results from a nationally representative survey[J].Chin Med J(Engl),2015,128(21):2843-2850.
[2] 趙德偉,楊磊,田豐德,等.大連市潛水員股骨頭壞死發(fā)病率的流行病學調查報告[J].中華骨科雜志,2012,32(6):521-525.
[3] MONT M A,HUNGERFORD D S.Non-traumatic avascular necrosis of the femoral head[J].J Bone Joint Surg Am,1995,77(3):459-474.
[4] GARDENIERS J W M.Report of the committee of staging and nomenclature[EB/OL].(1993-10-14)[2019-08-03].http://arco-intl.org/Newsletters/Gardeniers-1993-5-2/Gardeniers-1993.htm.
[5] YOSHII I,CHIJIWA T,SAWADA N.Influence of pain score measured by a visual analog scale(PS-VAS)on the health assessment questionnaire disability index and 28-joint disease activity index with C-reactive protein in rheumatoid arthritis patients[J].Int J of Rheum Dis,2018,21(11):1995-1961.
[6] EDWARDS P K,QUEEN R M,BUTLER R J,et al.Are range of motion measurements needed when calculating the Harris hip score?[J].J Arthroplasty,2016,31(4):815-819.
[7] 李泰賢,沈丹青,薛志鵬,等.針刀療法改善股骨頭壞死關節(jié)功能的近期療效觀察[J].中國中醫(yī)骨傷科雜志,2018,26(4):24-28.
[8] 陳衛(wèi)衡,金智勇,周宇,等.髖關節(jié)骨髓水腫與股骨頭壞死的相關性研究[J].中國矯形外科雜志,2009,17(3):187-189.
[9] 劉丙立,趙剛,王雪,等.早中期股骨頭壞死疼痛與壞死面積及關節(jié)積液分級相關性分析[J].實用骨科雜志,2015,21(11):1001-1004.
[10] 李子榮.股骨頭壞死成功保髖新理念[J].中醫(yī)正骨,2018,30(10):1-3.
[11] 王帥,張宏軍,張延召,等.細針多孔道鉆孔減壓術聯(lián)合體外沖擊波治療早期股骨頭壞死療效觀察[J].風濕病與關節(jié)炎,2015,4(1):41-43.
[12] 田志,徐朝健,馮毅,等.早期非創(chuàng)傷性股骨頭壞死診斷及治療的研究現(xiàn)狀[J].中國骨與關節(jié)損傷雜志,2016,31(6):116-118.
[13] üNAL M B,CANSU E,PARMAKSIZOGLU F,et al.Treatment of osteonecrosis of the femoral head with free vascularized fibular grafting:results of 7.6-year follow-up[J].Acta Orthop Traumatol Turc,2016,50(5):501-506.
[14] 柴偉.股骨頭壞死的人工全髖關節(jié)置換術治療[J].中國臨床醫(yī)生,2013,41(8):73-78.
[15] MONT M A,JONES L C,HUNGERFORD D S.Nontraumatic osteonecrosis of the femoral head:ten years later[J].J Bone Joint Surg Am,2006,88(5):1117-1132.
[16] 何偉.整體觀念在股骨頭壞死診斷與治療中的應用[J].江蘇中醫(yī)藥,2008,40(5):1-2.
[17] 亓強,韓銘.中醫(yī)藥治療股骨頭壞死的研究概況[J].世界最新醫(yī)學信息文摘,2018,18(72):62-63.
[18] 中華醫(yī)學會骨科分會顯微修復學組及中國修復重建外科專業(yè)委員會骨缺損及骨壞死學組.成人股骨頭壞死診療標準專家共識(2012年版)[J].中國骨與關節(jié)外科,2012,5(2):185-192.
[19] 陳衛(wèi)衡,周宇,何海軍,等.健脾活骨方治療早中期非創(chuàng)傷性股骨頭壞死臨床回顧性研究[J].中國中西醫(yī)結合雜志,2013,33(8):1054-1058.
[20] 陳雷雷,何偉,張慶文,等.中醫(yī)藥治療股骨頭壞死臨床試驗的系統(tǒng)評價[J].中華中醫(yī)藥雜志,2012,27(3):710-715.
[21] 崔國祥,徐健,鮑喜福,等.中醫(yī)+介入治療早期股骨頭缺血性壞死的療效評價[J].醫(yī)學信息(手術學分冊),2007,20(4):295-297.
[22] 顧一帆,韋標方.中藥聯(lián)合病灶清除減壓植骨術治療圍塌陷期股骨頭壞死療效觀察[J].風濕病與關節(jié)炎,2015,4(10):34-35.
相似文獻/References:
[1]陳雷雷,張穎.何偉教授采用中醫(yī)藥療法治療股骨頭壞死的經(jīng)驗[J].中醫(yī)正骨,2015,27(10):74.
[2]徐西林,趙永蘭,張曉峰,等.活骨注射液髖關節(jié)腔灌注對兔股骨頭壞死模型
血管內皮生長因子表達的動態(tài)影響[J].中醫(yī)正骨,2015,27(08):1.
XU Xilin,ZHAO Yonglan,ZHANG Xiaofeng,et al.Dynamic effect of intra-articular hip injection of Huogu injection on the expression of vascular endothelial growth factor in rabbit models with femur head necrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):1.
[3]周勇,任菲菲,豐凡翔,等.血管內皮生長因子和骨形態(tài)發(fā)生蛋白2
在非創(chuàng)傷性股骨頭壞死不同區(qū)域的表達[J].中醫(yī)正骨,2015,27(08):7.
ZHOU Yong,REN Feifei,FENG Fanxiang,et al.Expressions of vascular endothelial growth factor and bone morphogenetic protein 2 in different zones of femoral head with non-traumatic osteonecrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):7.
[4]鮑榮華,王國平,夏曉斌,等.鉭棒植入治療非創(chuàng)傷性股骨頭壞死的療效觀察[J].中醫(yī)正骨,2015,27(02):28.
[5]張兵,馬凰富,劉波,等.非創(chuàng)傷性股骨頭壞死的舌象定量研究[J].中醫(yī)正骨,2015,27(04):8.
ZHANG Bing,MA Huangfu,LIU Bo,et al.Quantitative study on tongue manifestation of patients with nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):8.
[6]李剛,程春生.股骨頭壞死血瘀證癥狀與平樂郭氏正骨方藥藥物組成
最大頻繁關聯(lián)模式挖掘[J].中醫(yī)正骨,2015,27(04):21.
LI Gang,CHENG Chunsheng.Maximal frequent association pattern mining for studying the relationship between BLOOD STASIS syndrome in patients with osteonecrosis of femoral head and drug components of Pingle Guo's orthopedics prescription[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):21.
[7]李文龍,梅沉成,杜貴強,等.微創(chuàng)減壓植骨多孔鉭棒植入治療
ARCOⅡ期非創(chuàng)傷性缺血性股骨頭壞死[J].中醫(yī)正骨,2016,28(02):43.
[8]張磊,金紅婷,童培建.骨健口服液早期干預非創(chuàng)傷性股骨頭壞死的臨床研究[J].中醫(yī)正骨,2016,28(03):14.
ZHANG Lei,JIN Hongting,TONG Peijian.Clinical study on Gujian Koufuye(骨健口服液)for early intervention of nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(01):14.
[9]鮑榮華,王國平,夏曉斌,等.直接前入路微創(chuàng)全髖關節(jié)置換術治療晚期股骨頭壞死[J].中醫(yī)正骨,2016,28(03):61.
[10]張超,姚晨,沈計榮.微創(chuàng)髓芯減壓打壓支撐植骨術結合補腎活血湯口服治療ARCOⅡ、Ⅲ期股骨頭壞死的近期療效觀察[J].中醫(yī)正骨,2016,28(03):20.
ZHANG Chao,YAO Chen,SHEN Jirong.[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(01):20.
[11]陳衛(wèi)衡.中國股骨頭壞死數(shù)據(jù)庫的現(xiàn)狀與挑戰(zhàn)[J].中醫(yī)正骨,2020,32(01):1.
[12]雷志強,曾平,陳衛(wèi)衡,等.中國股骨頭壞死數(shù)據(jù)庫股骨頭壞死流行病學特點分析[J].中醫(yī)正骨,2020,32(01):4.
[13]周占國,郭浩山,關濤,等.股骨頭壞死病因的相關因素分析[J].中醫(yī)正骨,2020,32(01):7.
[14]陳瑞,董博,袁普衛(wèi),等.股骨頭壞死誤診原因分析[J].中醫(yī)正骨,2020,32(01):11.
[15]楊琪,杜炯,孫繼高,等.股骨頭壞死中醫(yī)證型分析[J].中醫(yī)正骨,2020,32(01):14.
[16]曹玉舉,崔朋濤,孫繼高,等.不同ARCO分期和中日友好醫(yī)院分型股骨頭壞死的中醫(yī)證型分布特征研究[J].中醫(yī)正骨,2020,32(01):18.
[17]莊至坤,郭金花,趙巖,等.股骨頭壞死髖關節(jié)疼痛和活動度與ARCO分期的相關性分析[J].中醫(yī)正骨,2020,32(01):21.
[18]范亞楠,李文龍,張穎,等.不同病因股骨頭壞死的ARCO分期和中日友好醫(yī)院分型特征研究[J].中醫(yī)正骨,2020,32(01):25.
[19]高歡歡,王向鵬,任浩,等.股骨頭壞死的舌象特征研究[J].中醫(yī)正骨,2020,32(01):28.
[20]薛志鵬,李記天,高歡歡,等.股骨頭壞死舌象特點的聚類分析[J].中醫(yī)正骨,2020,32(01):32.